Project Grant RF1NS142354
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$1.3M
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This three-year, $5.782 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will support research into single-cell characterization of frontotemporal lobar degeneration caused by mutations in the progranulin gene. The University of California, San Francisco will map the transcriptome and gene regulatory networks that define glial pathology and neuronal vulnerability in the frontal cortex and thalamus of progranulin-deficient...
This Project Grant award, valued at $3,841,367.00 and awarded by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) program, supports research to comprehensively understand the role of the TBK1 protein kinase and associated autophagy pathways in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The research, conducted by the University of California, San Francisco (UCSF), aims to: 1) identify novel TBK1 substrates and characterize the effects of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $663,376 to The Regents of the University of California, San Francisco (UCSF) to conduct research exploring the differential spreading of distinct pathological conformers of proteins associated with Alzheimer's disease, Lewy body dementia, and related dementias. The project aims to identify candidate genes responsible for the selective regional vulnerability to these distinct pathological...
This three-year, $4.2 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research into resolving the function of progranulin in lysosomal lipid metabolism and its role in the etiology of Alzheimer's disease and frontotemporal dementia. Specifically, the grantee, Emory University, will determine global and lysosome-specific molecular defects caused by progranulin deficiency in human induced pluripotent stem cell-derived...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $816,661 to The Regents of the University of California, San Francisco to conduct research aimed at elucidating the molecular and cellular mechanisms by which pathological tau protein drives neurodegeneration in Alzheimer's disease (AD) and related tauopathies. The research leverages expertise in mass spectrometry-based proteomics and functional genomics to comprehensively map the impact of tau...
This Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, provides $757,027.00 to the University of Washington to investigate the synergistic relationship between tau and TDP-43 proteins in Alzheimer's disease (AD). The research aims to elucidate the mechanisms by which the combination of tau and TDP-43 pathologies drives more rapid cognitive decline and hippocampal atrophy compared to tau pathology alone. Key objectives include using C. elegans...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD). The project aims to develop new...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop synthetic replicas of TDP-43 protein filaments associated with frontotemporal dementia and other neurodegenerative diseases. The $442,750 award to Case Western Reserve University will fund research to generate in vitro amyloid fibrils with structures identical to brain-derived TDP-43 filaments. This synthetic model would enable mechanistic studies on disease-relevant TDP-43 aggregation...
The National Institute on Aging awarded a $1,198,947 Project Grant under the Aging Research program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) on September 30, 2023. The grant will fund research to investigate the neuroprotective effects of a blood-derived enzyme called GPLD1 on Alzheimer's disease pathology. Specifically, the project aims to: 1) examine the relationships between GPLD1, physical activity, immunovascular function, and cognition in older...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research into proteostasis, neuroinflammation, and neurodegeneration in frontotemporal dementia (FTD). The $630,496 award, granted on June 1, 2025, aims to better define alterations in proteostasis in FTD glial cells, including microglia and astrocytes, and determine if proteostasis impairment in glia, neurons, or both drives neurodegeneration in FTD. The research is being conducted by the J....